Globus Medical (GMED) Misses Q4 EPS by 2c

Globus Medical (NYSE: GMED) reported Q4 EPS of $0.31, $0.02 worse than the analyst estimate of $0.33. Revenue for the quarter came in at $151.6 million versus the consensus estimate of $149.3 million.

GUIDANCE:

Globus Medical sees FY2017 EPS of $1.27, versus the consensus of $1.27. Globus Medical sees FY2017 revenue of $625 million, versus the consensus of $624 million.

For earnings history and earnings-related data on Globus Medical (GMED) click here.

You May Also Be Interested In

• EU proposes to curb Airbnb and short-term rentals amid housing shortage
• Oxford Industries (OXM) Tops Q2 EPS by 4c; offers guidance
• UBS Upgrades Eaton Corporation (ETN) to Buy